- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04271761
Evaluation of Carina Microphone Sensitivity and Maximum Stable Gain in Adult Recipients (CAMSEN)
A Prospective, Single-centre Evaluation of Carina Microphone Sensitivity and Maximum Stable Gain in Adult Recipients
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The totally implanted Carina System is an active middle ear implant where all components are implanted under the skin. Placing a microphone under the skin affects its acoustic sensitivity and vibration sensitivity. Software is now available to enable non-intrusive microphone measurements in existing patients with the Carina device, through a wireless link to the implant. Detailed knowledge of the acoustic sensitivity of the implanted microphone and objectively measured maximum stable gain, and its inter-individual variability, will allow more accurate calculation of overall system performance, and thereby more accurate prediction of clinical outcomes.
Subjects will attend one scheduled study visit to be assessed; several objective acoustic measurements will be performed that do not require active participation from the subject. No data monitoring committee will be used for this clinical investigation.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Porto, Portugal, 4100-180
- CUF Porto Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Eighteen years of age or older at the time of enrolment in the study
- Current recipient of a Cochlear Carina System.
Exclusion Criteria:
- Unwillingness or inability of the candidate to comply with all investigational requirements as determined by the Investigator.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Current adult recipients of Cochlear Carina System
Adults who are current recipients of the Cochlear Carina System.
Participants will attend one scheduled visit where several acoustic measurements will be taken that do not require active participation by the participant.
|
Several objective acoustic measurements will be performed that do not require active participation from the subject.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Acoustic Sensitivity of Implanted Carina Microphone
Time Frame: from date of enrolment through to study visit, an average of 1 month
|
The acoustic sensitivity of the implanted microphone was measured using a white noise acoustic test signal was presented from a loudspeaker, with the sound pressure level monitored with an external probe microphone positioned over the location of the implanted microphone and the signal level at the implanted microphone recorded through a wireless link to the Carina implant.
|
from date of enrolment through to study visit, an average of 1 month
|
Ratio of Response of Carina Microphone : Accelerometer for Acoustic Stimulation
Time Frame: from date of enrolment through to study visit, an average of 1 month
|
Ratio [dB] of response of implanted microphone to response of implanted accelerometer, in-situ, for audiometric frequencies 250-6000 Hz, median and percentiles
|
from date of enrolment through to study visit, an average of 1 month
|
Carina Maximum Stable Gain
Time Frame: from date of enrolment through to study visit, an average of 1 month
|
Transfer function from Carina output to actuator [dB FS] to Carina input from implanted microphone [dB FS], for audiometric frequencies 250-6000 Hz, with ear canal open and ear canal plugged.
|
from date of enrolment through to study visit, an average of 1 month
|
Carina Microphone Impulse Response for Acoustic and Actuator Stimulation
Time Frame: from date of enrolment through to study visit, an average of 1 month
|
Identification of the system's acoustic and vibration transfer functions including non-linear components.
|
from date of enrolment through to study visit, an average of 1 month
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Victor Correia da Silva, MD, CUF Porto
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- AI-5770
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hearing Impairment
-
University of North Carolina, Chapel HillMed-El CorporationActive, not recruitingHigh Frequency Sensorineural Hearing Impairment | Hearing Disorders in ChildrenUnited States
-
Washington University School of MedicineNational Institute on Aging (NIA)CompletedHearing Impairment, SensorineuralUnited States
-
CochlearRecruitingHearing Impairment, SensorineuralBelgium, United States
-
University of Southern DenmarkInnovation Fund Denmark; William Demant FondenRecruitingHearing Loss, Sensorineural | Hearing Impairment, SensorineuralDenmark
-
CochlearTerminatedHearing Impairment, SensorineuralArgentina
-
Radboud University Medical CenterOticon MedicalRecruitingHearing Impaired Children | Hearing Impairment, ConductiveNetherlands
-
Radboud University Medical CenterCochlear Bone Anchored SolutionsRecruitingHearing Impaired Children | Hearing Impairment, ConductiveNetherlands
-
CochlearAvaniaCompletedHearing Impairment, SensorineuralAustralia
-
Oticon MedicalCompletedHearing Impairment, Conductive | Deafness Unilateral | Hearing Impaired (Partially)Denmark
-
University Hospital Inselspital, BerneCochlear; Stiftung Besser HörenTerminatedHearing-ImpairmentSwitzerland
Clinical Trials on Non-interventional, post-market, pilot study of Carina Cochlear System
-
Asklepios proresearchAG PregnoliaRecruiting
-
Sinew Pharma Inc.CompletedAcetaminophen ToxicityTaiwan
-
Hospital for Special Surgery, New YorkCompletedSpinal Stenosis | Spondylosis | Lumbar Disc Disease | Lumbar OsteoarthritisUnited States
-
Johns Hopkins UniversityTerminated
-
Alberta Children's HospitalRecruitingPain, Postoperative | Balanitis | Phimosis | ParaphimosisCanada
-
SWOG Cancer Research NetworkProteus Digital Health, Inc.Terminated
-
Pfizer's Upjohn has merged with Mylan to form Viatris...CompletedPeripheral Neuropathic Pain
-
University Hospital of PatrasCompleted
-
University of NebraskaTerminatedPain, Postoperative | Body Weight Changes | Postoperative Nausea and Vomiting | Postoperative HemorrhageUnited States
-
Baylor College of MedicineThe Methodist Hospital Research Institute; Center for Cell and Gene Therapy...Active, not recruitingChronic Lymphocytic Leukemia (CLL) | Acute Lymphoblastic Leukemia (ALL) | Non Hodgkin's LymphomaUnited States